• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Lotrel (amlodipine besylate/benazepril hydrochloride) capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- October 2009

 

Summary View

 

CONTRAINDICATIONS

  • Lotrel is contraindicated in patients with a history of angioedema, with or without previous ACE inhibitor treatment or patients who are hypersensitive to benazepril, to any other ACE inhibitor, or to amlodipine.

PRECAUTIONS

Drug Interactions

  • Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy.